Long-term survival following SCLC transformation after osimertinib resistance in EGFR -mutant NSCLC: Benefit from local surgical resection and osimertinib rechallengeZhang Q.Genes Dis · 2026-03-06 · PMID 42698678在知镜精读原文来源DOI 原文